Retinoic Acid Enhances Apolipoprotein E Synthesis in Human Macrophages.
Apolipoprotein E (ApoE) represents a pivotal target in Alzheimer's disease (AD) and is modulated through retinoic acid (RA), an endogenous neuroprotective and anti-inflammatory compound. A major source of ApoE are microglia, which are pathologically activated in AD. Activated microglia are known to block RA signaling. This suggests a vicious cycle between inflammation, RA signaling, and ApoE homeostasis in AD pathogenesis. To test this hypothesis, we investigated effects of RA and proinflammatory activation on ApoE synthesis in primary human macrophage-derived microglial-like cells. Our results indicate that proinflammatory activation attenuates ApoE synthesis, an effect blocked by RA.
['Clemens|Vera|V|', 'Regen|Francesca|F|', 'Le Bret|Nathalie|N|', 'Heuser|Isabella|I|', 'Hellmann-Regen|Julian|J|']
D000544:Alzheimer Disease D001057:Apolipoproteins E D002478:Cells, Cultured D006801:Humans D008264:Macrophages D015398:Signal Transduction D014212:Tretinoin
retinoic acid Apolipoprotein E macrophages Alzheimer’s disease vitamin A